Old Web
English
Sign In
Acemap
>
authorDetail
>
Susan Burdette-Radoux
Susan Burdette-Radoux
McGill University
Medicine
Cancer
Chemotherapy
Anesthesia
Melanoma
5
Papers
108
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma
2004
Investigational New Drugs
Susan Burdette-Radoux
Richard Tozer
Reinhard Lohmann
Ian Quirt
D. Scott Ernst
Wendy Walsh
Nancy Wainman
A. Dimitrios Colevas
Elizabeth Eisenhauer
Show All
Source
Cite
Save
Citations (80)
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma.
2003
Investigational New Drugs
Karl Belanger
David R. Macdonald
Gregory Cairncross
Stan Gertler
Peter A. Forsyth
Susan Burdette-Radoux
Julie Bergeron
Denis Soulières
Samuel K. Ludwin
Nancy Wainman
Elizabeth Eisenhauer
Show All
Source
Cite
Save
Citations (7)
A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study
2002
Investigational New Drugs
R. Tozer
Susan Burdette-Radoux
K. Berlanger
M. L. Davis
R. C. Lohmann
J. R. Rusthoven
Nancy Wainman
Benny Zee
Lesley Seymour
Show All
Source
Cite
Save
Citations (17)
Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule
1999
European Journal of Cancer
Karl Belanger
R. Tozer
Susan Burdette-Radoux
M. L. Davis
R Lohmann
Benny Zee
Nancy Wainman
Lesley Seymour
Show All
Source
Cite
Save
Citations (2)
Management of hepatic metastases from colorectal cancer: Systemic chemotherapy
1997
Journal of Gastrointestinal Surgery
Brian Leyland-Jones
Susan Burdette-Radoux
Show All
Source
Cite
Save
Citations (2)
1